Present Rationality for combining FDC: CDSCO panel Tells Akum Pharma on Lobeglitazone, Sitagliptin FDC Dr. Divya Colin1 July 2023 6:00 PM ISTNew Delhi: Regarding the antidiabetic fixed dose combination drug, Lobeglitazone sulfate 0.25mg/0.25mg plus Sitagliptin Phosphate monohydrate...
Glimepiride Stands Tall on Cardiovascular Safety Again: Latest Update Dr. Prem Aggarwal9 Jun 2023 11:36 AM ISTThe epidemiologic link between diabetes & heart failure is well established, with a burden of heart failure among 22% of patients with diabetes...
Alkem Gets CDSCO Panel Nod To Manufacture, Market Linagliptin, Dapagliflozin antidiabetic FDC Dr. Divya Colin2 Jun 2023 6:00 PM ISTNew Delhi: The drug major Alkem Health Sciences has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
AstraZeneca gets CDSCO panel nod to Market Dapagliflozin to treat heart failure in adult Dr. Divya Colin31 May 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Akum Gets CDSCO Panel Nod to Study Antidiabetic FDC Drug Dr. Divya Colin28 May 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceuticals has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Akum Gets CDSCO Panel Nod to Manufacture, Market Glimepiride, Lobeglitazone FDC Dr. Divya Colin22 May 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceuticals has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Synokem Pharma Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Dr. Divya Colin18 May 2023 6:00 PM ISTNew Delhi: Granting the Phase III clinical trial study waiver for the proposed antidiabetic fixed-dose combination (FDC), the Subject Expert Committee...
Sun Pharma Gets CDSCO panel nod to manufacture, market antidiabetic FDC drug Dr. Divya Colin24 Feb 2023 6:00 PM ISTNew Delhi: In a significant development, pharmaceutical major, Sun Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional...
Dr. Reddy proposal to market antidiabetic FDC of Imeglimin and Vildagliptin rejected by CDSCO Panel Dr. Divya Colin2 Nov 2022 6:00 PM ISTNew Delhi: Noting that the clinical experience with the drug Imeglimin is very limited, the Subject Expert Committee (SEC) functional under the...
Glenmark gets CDSCO Panel nod to manufacture,market Lobeglitazone, Metformin antidiabetic FDC Susmita Roy31 Oct 2022 6:00 PM ISTNew Delhi: Highlighting the clinical trial results that demonstrate the efficacy and safety of combination treatment of Lobeglitazone and Metformin in...
USV slashes price of diabetes drug Jalra DP by 20 percent Dr. Nandita Mohan10 Oct 2022 2:02 PM ISTIn a move to make diabetes therapy more accessible to patients, Indian pharma major USV has brought down the price of its product Jalra-DP,...
Submit complete CT Report :CDSCO Tells Glenmark on antidiabetic FDC drug Dr. Divya Colin23 Sept 2022 6:00 PM ISTNew Delhi: In response to drug major Glenmark proposal to manufacture and market the antidiabetic fixed dose combination Lobeglitazone Sulphate...
